A Booster Study of S-268023 (COVID-19)
Phase 3
- Conditions
- Prevention of COVID-19
- Registration Number
- JPRN-jRCT2031230503
- Lead Sponsor
- Gomez Juan Carlos
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 600
Inclusion Criteria
Participants aged 20 years or older, at the time of sigining the informed consent form.
-Participants who have passed 90 days or more after completing the primary vaccination or booster vaccination with an approved SARS-CoV-2 vaccine (excluding an approved monovalent XBB.1.5 SARS-CoV-2 vaccine).
-Participants with no infection history of SARS-CoV-2, or participants with infection history of SARS-CoV-2 who have not been infected since March 2023.
-Male and female.
Exclusion Criteria
-Participants who have previously received an approved monovalent XBB.1.5 SARS-CoV-2 vaccines.
-Participants who tested positive SARS-CoV-2 infection (as determined by SARS-CoV-2 antigen test) at Screening.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method